Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. S-8 POS Other Post-effective Amendment
  3. 10-K Report Annual Report
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 8-K Event Regulation FD disclosure
  7. SC 13G Stake Amended Statement of Ownership
  8. 8-K Event Other events
  9. 8-K Event Other events
  10. 8-K Event Regulation FD disclosure · Other events
  11. 8-K Event Regulation FD disclosure · Other events
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-Q Report Quarterly Report
  14. 8-K Event Material agreement
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Open-market sale 10% owner sold 2,756,499 shares at an average $1.62 ($4,453,308)
  17. 8-K Event Other events
  18. SC 13G Stake Amended Statement of Ownership
  19. 4 Shares withheld for taxes President and CEO gave up 73,807 shares (to pay taxes)
  20. 4 Option exercise Director acquired 5,437 shares (option exercise)

Page 7 of 33 · 650 filings